Moreover, the growing interest in rare complex diseases, such as Fabry disease, has revealed that FSGS may hide mutations in the GLA gene leading to lysosomal dysfunction, manifesting glomerulosclerosis features at the kidney level. This evidence concerns the gene GLA and focal segmental glomerulosclerosis.